<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Health Science Monitor</title>
<title_fa>Health Science Monitor</title_fa>
<short_title>Health Science Monitor</short_title>
<subject>Basic Sciences</subject>
<web_url>http://hsm.umsu.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn></journal_id_issn>
<journal_id_issn_online>2980-8723</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>10.61882/hsm</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>9104634</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1404</year>
	<month>2</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2025</year>
	<month>5</month>
	<day>1</day>
</pubdate>
<volume>4</volume>
<number>2</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Development of novel antimicrobial agents: investigating the efficacy of 1,3,5-Triphenyl-2-pyrazoline derivatives</title>
	<subject_fa>عمومى</subject_fa>
	<subject>General</subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Research Article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;span style=&quot;font-size:12pt&quot;&gt;&lt;span style=&quot;line-height:16.0pt&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;&lt;b&gt;&lt;i&gt;&lt;span style=&quot;font-size:9.0pt&quot;&gt;Background &amp; Aims&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;span style=&quot;font-size:9.0pt&quot;&gt;: &lt;/span&gt;&lt;/b&gt;&lt;span lang=&quot;EN-GB&quot; style=&quot;font-size:9.0pt&quot;&gt;In this research, a novel series of heterocyclic compounds containing pyrazoline nuclei was synthesized in two steps.&lt;/span&gt; &lt;span style=&quot;font-size:9.0pt&quot;&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:12pt&quot;&gt;&lt;span style=&quot;line-height:16.0pt&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;&lt;b&gt;&lt;i&gt;&lt;span style=&quot;font-size:9.0pt&quot;&gt;Materials &amp; Methods&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;span style=&quot;font-size:9.0pt&quot;&gt;:&lt;/span&gt;&lt;/b&gt; &lt;span lang=&quot;EN-GB&quot; style=&quot;font-size:9.0pt&quot;&gt;I&lt;/span&gt;&lt;span lang=&quot;TR&quot; style=&quot;font-size:9.0pt&quot;&gt;n the first step, chalcones were prepared using the Claisen-Schmidt reaction between substituted benzaldehydes and acetophenone derivatives. In the second step, t&lt;/span&gt;&lt;span lang=&quot;EN-GB&quot; style=&quot;font-size:9.0pt&quot;&gt;he chalcones were cyclized under acidic conditions with hydrazine derivatives to produce pyrazolines. &lt;/span&gt;&lt;span lang=&quot;TR&quot; style=&quot;font-size:9.0pt&quot;&gt;All compounds were characterized through &lt;/span&gt;&lt;span lang=&quot;EN-GB&quot; style=&quot;font-size:9.0pt&quot;&gt;physical, chromatographic, spectroscopic, and elemental analyses, and their antibacterial properties were tested using seven microorganisms. The minimum inhibitory concentrations of all compounds were determined using the broth dilution method.&lt;/span&gt; &lt;b&gt;&lt;span style=&quot;font-size:9.0pt&quot;&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:12pt&quot;&gt;&lt;span style=&quot;line-height:16.0pt&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;&lt;b&gt;&lt;i&gt;&lt;span style=&quot;font-size:9.0pt&quot;&gt;Results&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;span style=&quot;font-size:9.0pt&quot;&gt;:&lt;/span&gt;&lt;/b&gt; &lt;span lang=&quot;EN-GB&quot; style=&quot;font-size:9.0pt&quot;&gt;Among them, compound 2f (4-(1, 5-diphenyl-4, 5-dihydro-1&lt;i&gt;H&lt;/i&gt;-pyrazol-3-yl) phenol)&lt;/span&gt; &lt;span lang=&quot;EN-GB&quot; style=&quot;font-size:9.0pt&quot;&gt;exhibited the highest antibacterial and antifungal activity, making it the &lt;/span&gt;&lt;span lang=&quot;TR&quot; style=&quot;font-size:9.0pt&quot;&gt;most potent compound in the series.&lt;/span&gt; &lt;b&gt;&lt;span style=&quot;font-size:9.0pt&quot;&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:12pt&quot;&gt;&lt;span style=&quot;line-height:16.0pt&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;&lt;b&gt;&lt;i&gt;&lt;span style=&quot;font-size:9.0pt&quot;&gt;Conclusion&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;span style=&quot;font-size:9.0pt&quot;&gt;: &lt;/span&gt;&lt;/b&gt;&amp;nbsp;&lt;span lang=&quot;EN-GB&quot; style=&quot;font-size:9.0pt&quot;&gt;These results indicate that increasing the polarity of the compounds enhanced their efficacy against Gram-positive strains, whereas derivatives containing at least one methoxy group in their structure suppressed Gram-negative growth.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Antibiotic resistance, Antimicrobial activity, Phenylhydrazine, Pyrazolines, Synthesis</keyword>
	<start_page>131</start_page>
	<end_page>139</end_page>
	<web_url>http://hsm.umsu.ac.ir/browse.php?a_code=A-10-305-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Sevda</first_name>
	<middle_name></middle_name>
	<last_name>Afzal-Ahangaran</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>sevdaafzal@gmail.com</email>
	<code>10031947532846003780</code>
	<orcid>10031947532846003780</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Medicinal Chemistry, School of Pharmacy, Urmia University of Medical Sciences, Urmia, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Yaeghob</first_name>
	<middle_name></middle_name>
	<last_name>Sharifi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>ya.sharifi@gmail.com</email>
	<code>10031947532846003781</code>
	<orcid>10031947532846003781</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Microbiology, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran </affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Maryam </first_name>
	<middle_name></middle_name>
	<last_name>Allahyari-Devin </last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>alahyaree@gmail.com</email>
	<code>10031947532846003782</code>
	<orcid>10031947532846003782</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Medicinal Chemistry, School of Pharmacy, Urmia University of Medical Sciences, Urmia, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
